Conversely, in the GCB-DLBCL subset, there is an activation of the phosphoinositide-3-kinase–protein kinase (PI3K) pathway signaling [27,28] Very recent studies using modern molecular technologies have attempted to further separate the genetic subtypes of DLBCL [29,30,31]. This evidence concerns the gene WEE1 and diffuse large B-cell lymphoma.